Literature DB >> 10094813

Differentiation-related mechanisms which suppress DNA replication.

F D Coffman1, G P Studzinski.   

Abstract

Differentiation of mammalian cells implies cessation of DNA replication and cell proliferation; the potential controls of this coupling are examined here. It is clear that the known or proposed mechanisms of down-regulation of replicative cellular activities vary in different lineages of cell differentiation, and occur in all phases of the cell cycle. In G1 these regulators include p21/Cip1 or p27/Kip1, pRb, and p53; the novel, recently reported mechanisms of their action are summarized. In S phase the availability of nucleotide precursors, the origin recognition complex (ORC), and other replication proteins may be important in differentiation, and in G2 phase the cdc2/cyclin B complex and replication licensing factors determine normal G2 traverse versus an arrest or polyploidisation. Other replication-related mechanisms include transcription factors, e.g., Sp1, telomerase, and nuclear matrix changes. Thus, differentiation alters the activity not only of the various checkpoint proteins, but also of the components of the replicative machinery itself. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10094813     DOI: 10.1006/excr.1999.4457

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

1.  Sequential actions of BMP receptors control neural precursor cell production and fate.

Authors:  D M Panchision; J M Pickel; L Studer; S H Lee; P A Turner; T G Hazel; R D McKay
Journal:  Genes Dev       Date:  2001-08-15       Impact factor: 11.361

Review 2.  Vitamin D and differentiation in cancer.

Authors:  Elzbieta Gocek; George P Studzinski
Journal:  Crit Rev Clin Lab Sci       Date:  2009       Impact factor: 6.250

3.  Adeno-associated virus type 2 increases proteosome-dependent degradation of p21WAF1 in a human papillomavirus type 31b-positive cervical carcinoma line.

Authors:  Samina Alam; Ellora Sen; Heidi Brashear; Craig Meyers
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Downregulation of Cdc2/CDK1 kinase activity induces the synthesis of noninfectious human papillomavirus type 31b virions in organotypic tissues exposed to benzo[a]pyrene.

Authors:  Samina Alam; Brian S Bowser; Michael J Conway; Mohd Israr; Eric J Ryndock; Long Fu Xi; Craig Meyers
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

5.  p27 expression in inflammatory bowel disease-associated neoplasia. Further evidence of a unique molecular pathogenesis.

Authors:  S Walsh; M Murphy; M Silverman; R Odze; D Antonioli; H Goldman; M Loda
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

6.  Loss of G(1)/S checkpoint in human immunodeficiency virus type 1-infected cells is associated with a lack of cyclin-dependent kinase inhibitor p21/Waf1.

Authors:  E Clark; F Santiago; L Deng; S Chong; C de La Fuente; L Wang; P Fu; D Stein; T Denny; V Lanka; F Mozafari; T Okamoto; F Kashanchi
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

7.  The requirement for and changing composition of the activating protein-1 transcription factor during differentiation of human leukemia HL60 cells induced by 1,25-dihydroxyvitamin D3.

Authors:  Xuening Wang; George P Studzinski
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

8.  TATA-binding protein-like protein (TLP/TRF2/TLF) negatively regulates cell cycle progression and is required for the stress-mediated G(2) checkpoint.

Authors:  Miho Shimada; Tomoyoshi Nakadai; Taka-Aki Tamura
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

Review 9.  Hox in hair growth and development.

Authors:  Alexander Awgulewitsch
Journal:  Naturwissenschaften       Date:  2003-04-26

10.  Induction of acute lymphocytic leukemia differentiation by maintenance therapy.

Authors:  T L Lin; M S Vala; J P Barber; J E Karp; B D Smith; W Matsui; R J Jones
Journal:  Leukemia       Date:  2007-07-05       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.